What is the recommended intravenous ceftizidime dosage for acute bacterial meningitis in adults and children, including adjustments for renal impairment?

Ceftazidime Dosing for Acute Bacterial Meningitis

For acute bacterial meningitis, ceftazidime should be dosed at 2 grams IV every 8 hours in adults, and 30-50 mg/kg IV every 8 hours (maximum 6 grams/day) in children aged 1 month to 12 years, with dose adjustments required for renal impairment. 1

Adult Dosing

The FDA-approved dosing for meningitis is 2 grams IV every 8 hours 1. This high-dose regimen is critical because:

• Ceftazidime penetrates the CSF with mean concentrations of approximately 9.4-9.8 mcg/mL when dosed at 2 g every 8 hours 1
• This achieves CSF levels 16- to >100-fold above the minimum bactericidal concentration for most susceptible pathogens 2
• The standard adult dose of 1 gram every 8-12 hours is insufficient for CNS infections 1

Important Clinical Context

While the provided guidelines [3-4] extensively discuss ceftriaxone and cefotaxime for bacterial meningitis, they do not recommend ceftazidime as a first-line agent. The UK and ESCMID guidelines consistently recommend:

• Ceftriaxone 2 g IV every 12 hours OR
• Cefotaxime 2 g IV every 6 hours 3, 4

Ceftazidime is not interchangeable with ceftriaxone or cefotaxime for empiric meningitis treatment because it lacks adequate coverage against Streptococcus pneumoniae and has different pharmacokinetic properties.

Pediatric Dosing

For children with meningitis:

• Neonates (0-4 weeks): 30 mg/kg IV every 12 hours 1
• Infants and children (1 month-12 years): 30-50 mg/kg IV every 8 hours, maximum 6 grams/day 1
• Higher doses (50 mg/kg) should be reserved for immunocompromised patients or those with cystic fibrosis 1

Clinical studies support 150 mg/kg/day divided every 8 hours for pediatric bacterial meningitis, particularly for Haemophilus influenzae 2, 5.

Renal Dose Adjustments

Ceftazidime is eliminated almost exclusively by glomerular filtration, requiring dose reduction when creatinine clearance falls below 50 mL/min 1:

Creatinine Clearance (mL/min)	Dose	Frequency
50-31	1 gram	Every 12 hours
30-16	1 gram	Every 24 hours
15-6	500 mg	Every 24 hours
<5	500 mg	Every 48 hours

Critical Dosing Principles for Renal Impairment:

• Give an initial loading dose of 1 gram regardless of renal function 1
• For severe infections requiring 6 grams/day in normal renal function, increase the maintenance dose by 50% or shorten the interval 1
• After hemodialysis: give 1 gram supplemental dose 1
• For peritoneal dialysis: loading dose of 1 gram, then 500 mg every 24 hours 1

Specific Pathogen Considerations

Ceftazidime has demonstrated efficacy in meningitis caused by:

• Haemophilus influenzae: Excellent activity with 100% inhibition at 0.78 mcg/mL 5
• Pseudomonas aeruginosa: Useful for Pseudomonas meningitis, though often requires 10-42 days of therapy 6
• Gram-negative Enterobacteriaceae: Good CSF penetration for susceptible organisms 2

However, ceftazidime has inferior activity against Streptococcus pneumoniae compared to ceftriaxone/cefotaxime and should not be used empirically when pneumococcal meningitis is suspected.

Common Pitfalls to Avoid

1. Do not use standard dosing (1 g every 8-12 hours) for meningitis—this achieves inadequate CSF concentrations
2. Do not substitute ceftazidime for ceftriaxone/cefotaxime in empiric meningitis treatment
3. Do not forget renal dose adjustments—ceftazidime accumulates rapidly in renal impairment with a half-life extending from 1.9 hours to >24 hours 7
4. Do not use ceftazidime alone for suspected pneumococcal meningitis—it is not the preferred cephalosporin for this indication

When Ceftazidime Is Appropriate

Consider ceftazidime specifically for:

• Documented Pseudomonas meningitis (often post-neurosurgical or in immunocompromised patients) 6
• Documented susceptible Gram-negative meningitis when ceftriaxone/cefotaxime are unavailable or contraindicated
• Haemophilus influenzae meningitis with documented susceptibility 2, 5